EPISODE · Jul 14, 2026 · 9 MIN
The Disappointment of the NSABP C-08 Trial
from Oncology Times - OncTimes Talk
Norman Wolmark on the study's frustrating but unequivocal results showing that bevacizumab did not extend disease-free survival in adjuvant therapy for early colon cancer at 3 years, even though there had been a benefit at 1 year. Also weighing in: Nicholas Petrelli
NOW PLAYING
The Disappointment of the NSABP C-08 Trial
0:00
9:05
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Times - OncTimes Talk?
This episode is 9 minutes long.
When was this Oncology Times - OncTimes Talk episode published?
This episode was published on July 14, 2026.
What is this episode about?
Norman Wolmark on the study's frustrating but unequivocal results showing that bevacizumab did not extend disease-free survival in adjuvant therapy for early colon cancer at 3 years, even though there had been a benefit at 1 year. Also weighing in:...
Can I download this Oncology Times - OncTimes Talk episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!